Stay updated on Durvalumab + Tremelumab in LS-SCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab + Tremelumab in LS-SCLC Clinical Trial page.

Latest updates to the Durvalumab + Tremelumab in LS-SCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAdded a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.SummaryDifference9%

- Check33 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.2%

- Check47 days agoChange DetectedVersion tag updated from v3.0.1 to v3.0.2; Back to Top link removed. No substantive changes to core content.SummaryDifference0.5%

- Check55 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.5%

- Check62 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, as well as various study status updates with specific dates. Notably, some previously listed location terms and dates have been removed.SummaryDifference53%

- Check76 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.3%

Stay in the know with updates to Durvalumab + Tremelumab in LS-SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab + Tremelumab in LS-SCLC Clinical Trial page.